Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Safety and pharmacokinetics of nelfinavir during the second and third trimesters of pregnancy and postpartum.

Fang A, Valluri SR, O'Sullivan MJ, Maupin R, Jones T, Delke I, Clax P.

HIV Clin Trials. 2012 Jan-Feb;13(1):46-59. doi: 10.1310/hct1301-046.

PMID:
22306587
2.

Pregnancy-associated mortality review: the Florida experience.

Burch D, Noell D, Hill WC, Delke I.

Semin Perinatol. 2012 Feb;36(1):31-6. doi: 10.1053/j.semperi.2011.09.007.

PMID:
22280863
3.

Psoas abscess in obstetrics: uncommon condition with common presentations.

Delke I.

Obstet Gynecol. 2010 Aug;116 Suppl 2:473-4. doi: 10.1097/AOG.0b013e3181eae617. No abstract available.

PMID:
20664422
4.

Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis.

Sanchez-Ramos L, Delke I, Zamora J, Kaunitz AM.

Obstet Gynecol. 2009 Sep;114(3):631-40. doi: 10.1097/AOG.0b013e3181b47217. Review.

PMID:
19701045
5.

Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.

Newell ML, Huang S, Fiore S, Thorne C, Mandelbrot L, Sullivan JL, Maupin R, Delke I, Watts DH, Gelber RD, Cunningham CK; PACTG 316 Study Team.

BMC Infect Dis. 2007 Jun 20;7:60.

6.

Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials.

Sanchez-Ramos L, Kaunitz AM, Delke I.

Obstet Gynecol. 2005 Feb;105(2):273-9. Review.

PMID:
15684151
7.

Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332.

Wade NA, Unadkat JD, Huang S, Shapiro DE, Mathias A, Yasin S, Ciupak G, Watts DH, Delke I, Rathore M, Hitti J, Frenkel L, Samelson R, Smith ME, Mofenson L, Burchett SK.

J Infect Dis. 2004 Dec 15;190(12):2167-74. Epub 2004 Nov 10.

8.

The impact of race/ethnicity on mother-to-child HIV transmission in the United States in Pediatric AIDS Clinical Trials Group Protocol 316.

Cunningham CK, Balasubramanian R, Delke I, Maupin R, Mofenson L, Dorenbaum A, Sullivan JL, Gonzalez-Garcia A, Thorpe E, Rathore M, Gelber RD.

J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):800-7.

PMID:
15213563
9.

Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316.

Watts DH, Balasubramanian R, Maupin RT Jr, Delke I, Dorenbaum A, Fiore S, Newell ML, Delfraissy JF, Gelber RD, Mofenson LM, Culnane M, Cunningham CK; PACTG 316 Study Team.

Am J Obstet Gynecol. 2004 Feb;190(2):506-16.

PMID:
14981398
10.

Special considerations for the HIV-infected patient with preterm labor.

Delke I.

Clin Perinatol. 2003 Dec;30(4):855-74. Review.

PMID:
14714926
11.

Human chorionic gonadotropin in cervicovaginal secretions as a predictor of preterm delivery.

Sanchez-Ramos L, Mentel C, Bertholf R, Kaunitz AM, Delke I, Loge C.

Int J Gynaecol Obstet. 2003 Nov;83(2):151-7.

PMID:
14550589
12.

Labor induction versus expectant management for postterm pregnancies: a systematic review with meta-analysis.

Sanchez-Ramos L, Olivier F, Delke I, Kaunitz AM.

Obstet Gynecol. 2003 Jun;101(6):1312-8. Review.

PMID:
12798542
13.

The effect of tablet moistening on labor induction with intravaginal misoprostol: a randomized trial.

Sanchez-Ramos L, Danner CJ, Delke I, Kaunitz AM.

Obstet Gynecol. 2002 Jun;99(6):1080-4.

PMID:
12052603
14.

Labor induction with 25 microg versus 50 microg intravaginal misoprostol: a systematic review.

Sanchez-Ramos L, Kaunitz AM, Delke I.

Obstet Gynecol. 2002 Jan;99(1):145-51. Review.

PMID:
11777525
15.
16.

Cervical ripening and labor induction with a controlled-release dinoprostone vaginal insert: a meta-analysis.

Sanchez-Ramos L, Kaunitz AM, Delke I, Gaudier FL.

Obstet Gynecol. 1999 Nov;94(5 Pt 2):878-83.

PMID:
10546777
17.

Efficacy of maintenance therapy after acute tocolysis: a meta-analysis.

Sanchez-Ramos L, Kaunitz AM, Gaudier FL, Delke I.

Am J Obstet Gynecol. 1999 Aug;181(2):484-90.

PMID:
10454704
18.

Induction of labor with misoprostol for premature rupture of membranes beyond thirty-six weeks' gestation.

Sanchez-Ramos L, Delke I.

Am J Obstet Gynecol. 1999 Jan;180(1 Pt 1):253-4. No abstract available.

PMID:
9914615
19.

Labor induction with prostaglandin E1 misoprostol compared with dinoprostone vaginal insert: a randomized trial.

Sanchez-Ramos L, Peterson DE, Delke I, Gaudier FL, Kaunitz AM.

Obstet Gynecol. 1998 Mar;91(3):401-5.

PMID:
9491868
20.

Randomized trial of two doses of the prostaglandin E1 analog misoprostol for labor induction.

Farah LA, Sanchez-Ramos L, Rosa C, Del Valle GO, Gaudier FL, Delke I, Kaunitz AM.

Am J Obstet Gynecol. 1997 Aug;177(2):364-9; discussion 369-71.

PMID:
9290452
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk